309 related articles for article (PubMed ID: 10996136)
1. Postischemic intracarotid treatment with TNK-tPA reduces infarct volume and improves neurological deficits in embolic stroke in the unanesthetized rat.
Zhang RL; Zhang L; Jiang Q; Zhang ZG; Goussev A; Chopp M
Brain Res; 2000 Sep; 878(1-2):64-71. PubMed ID: 10996136
[TBL] [Abstract][Full Text] [Related]
2. Intravenous administration of a GPIIb/IIIa receptor antagonist extends the therapeutic window of intra-arterial tenecteplase-tissue plasminogen activator in a rat stroke model.
Zhang L; Zhang ZG; Zhang C; Zhang RL; Chopp M
Stroke; 2004 Dec; 35(12):2890-5. PubMed ID: 15514182
[TBL] [Abstract][Full Text] [Related]
3. Postischemic (6-Hour) treatment with recombinant human tissue plasminogen activator and proteasome inhibitor PS-519 reduces infarction in a rat model of embolic focal cerebral ischemia.
Zhang L; Zhang ZG; Zhang RL; Lu M; Adams J; Elliott PJ; Chopp M
Stroke; 2001 Dec; 32(12):2926-31. PubMed ID: 11739997
[TBL] [Abstract][Full Text] [Related]
4. Early (1 h) administration of tissue plasminogen activator reduces infarct volume without increasing hemorrhagic transformation after focal cerebral embolization in rats.
Zhang RL; Chopp M; Zhang ZG; Divine G
J Neurol Sci; 1998 Sep; 160(1):1-8. PubMed ID: 9804110
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant treatment with a glycoprotein IIb/IIIa receptor inhibitor increases the therapeutic window for low-dose tissue plasminogen activator administration in a rat model of embolic stroke.
Zhang L; Zhang ZG; Zhang R; Morris D; Lu M; Coller BS; Chopp M
Circulation; 2003 Jun; 107(22):2837-43. PubMed ID: 12756151
[TBL] [Abstract][Full Text] [Related]
6. Extension of the therapeutic window for recombinant tissue plasminogen activator with argatroban in a rat model of embolic stroke.
Morris DC; Zhang L; Zhang ZG; Lu M; Berens KL; Brown PM; Chopp M
Stroke; 2001 Nov; 32(11):2635-40. PubMed ID: 11692028
[TBL] [Abstract][Full Text] [Related]
7. A new rat model of thrombotic focal cerebral ischemia.
Zhang Z; Zhang RL; Jiang Q; Raman SB; Cantwell L; Chopp M
J Cereb Blood Flow Metab; 1997 Feb; 17(2):123-35. PubMed ID: 9040491
[TBL] [Abstract][Full Text] [Related]
8. Comparison of TNK with wild-type tissue plasminogen activator in a rabbit embolic stroke model.
Chapman DF; Lyden P; Lapchak PA; Nunez S; Thibodeaux H; Zivin J
Stroke; 2001 Mar; 32(3):748-52. PubMed ID: 11239197
[TBL] [Abstract][Full Text] [Related]
9. Effects of the spin trap agent disodium- [tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) on intracerebral hemorrhage in a rabbit Large clot embolic stroke model: combination studies with tissue plasminogen activator.
Lapchak PA; Araujo DM; Song D; Wei J; Purdy R; Zivin JA
Stroke; 2002 Jun; 33(6):1665-70. PubMed ID: 12053009
[TBL] [Abstract][Full Text] [Related]
10. Effects of nonpeptide V(1) vasopressin receptor antagonist SR-49059 on infarction volume and recovery of function in a focal embolic stroke model.
Shuaib A; Xu Wang C; Yang T; Noor R
Stroke; 2002 Dec; 33(12):3033-7. PubMed ID: 12468809
[TBL] [Abstract][Full Text] [Related]
11. Combination treatment with low-dose Niaspan and tissue plasminogen activator provides neuroprotection after embolic stroke in rats.
Shehadah A; Chen J; Cui Y; Zhang L; Roberts C; Lu M; Chopp M
J Neurol Sci; 2011 Oct; 309(1-2):96-101. PubMed ID: 21802695
[TBL] [Abstract][Full Text] [Related]
12. Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats.
Asahi M; Asahi K; Wang X; Lo EH
J Cereb Blood Flow Metab; 2000 Mar; 20(3):452-7. PubMed ID: 10724108
[TBL] [Abstract][Full Text] [Related]
13. Effects of tissue plasminogen activator and annexin A2 combination therapy on long-term neurological outcomes of rat focal embolic stroke.
Wang X; Fan X; Yu Z; Liao Z; Zhao J; Mandeville E; Guo S; Lo EH; Wang X
Stroke; 2014 Feb; 45(2):619-22. PubMed ID: 24368559
[TBL] [Abstract][Full Text] [Related]
14. Atorvastatin extends the therapeutic window for tPA to 6 h after the onset of embolic stroke in rats.
Zhang L; Chopp M; Jia L; Cui Y; Lu M; Zhang ZG
J Cereb Blood Flow Metab; 2009 Nov; 29(11):1816-24. PubMed ID: 19638998
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic stroke.
Zhang Z; Zhang L; Yepes M; Jiang Q; Li Q; Arniego P; Coleman TA; Lawrence DA; Chopp M
Circulation; 2002 Aug; 106(6):740-5. PubMed ID: 12163437
[TBL] [Abstract][Full Text] [Related]
16. The nonpeptide glycoprotein IIb/IIIa platelet receptor antagonist SM-20302 reduces tissue plasminogen activator-induced intracerebral hemorrhage after thromboembolic stroke.
Lapchak PA; Araujo DM; Song D; Zivin JA
Stroke; 2002 Jan; 33(1):147-52. PubMed ID: 11779904
[TBL] [Abstract][Full Text] [Related]
17. Vepoloxamer Enhances Fibrinolysis of tPA (Tissue-Type Plasminogen Activator) on Acute Ischemic Stroke.
Wang C; Huang R; Li C; Lu M; Emanuele M; Zhang ZG; Chopp M; Zhang L
Stroke; 2019 Dec; 50(12):3600-3608. PubMed ID: 31587657
[TBL] [Abstract][Full Text] [Related]
18. Opening the window: Ischemic postconditioning reduces the hyperemic response of delayed tissue plasminogen activator and extends its therapeutic time window in an embolic stroke model.
Esmaeeli-Nadimi A; Kennedy D; Allahtavakoli M
Eur J Pharmacol; 2015 Oct; 764():55-62. PubMed ID: 26123846
[TBL] [Abstract][Full Text] [Related]
19. Effects of a selective CD11b/CD18 antagonist and recombinant human tissue plasminogen activator treatment alone and in combination in a rat embolic model of stroke.
Zhang L; Zhang ZG; Zhang RL; Lu M; Krams M; Chopp M
Stroke; 2003 Jul; 34(7):1790-5. PubMed ID: 12805500
[TBL] [Abstract][Full Text] [Related]
20. Transient brain hypothermia reduces the reperfusion injury of delayed tissue plasminogen activator and extends its therapeutic time window in a focal embolic stroke model.
Zarisfi M; Allahtavakoli F; Hassanipour M; Khaksari M; Rezazadeh H; Allahtavakoli M; Taghavi MM
Brain Res Bull; 2017 Sep; 134():85-90. PubMed ID: 28710023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
